A Study of Juvenile Idiopathic Arthritis Patients Given Abatacept and the Number of Infections or Malignancies That Occur
| Status: | Completed |
|---|---|
| Conditions: | Arthritis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 12/9/2018 |
| Start Date: | July 12, 2016 |
| End Date: | September 30, 2016 |
Supplemental Data for the Juvenile Idiopathic Arthritis FDA Written Request
This study will determine the incidences of infections and malignancies among JIA patients
treated with abatacept
treated with abatacept
Inclusion Criteria:
- Two diagnoses of JIA (ICD-9 code 714.3x) within 90 days
- Age less than 18 years at the time of second of the two diagnoses
- Index date is the date of initiating treatment with abatacept
Exclusion Criteria:
- Greater than or equal to 18 years of age
We found this trial at
1
site
Click here to add this to my saved trials
